Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019.

Capuano I, Garofalo C, Buonanno P, Pinelli M, Di Risi T, Feriozzi S, Riccio E, Pisani A.

J Nephrol. 2019 Oct 24. doi: 10.1007/s40620-019-00663-6. [Epub ahead of print]

PMID:
31650418
2.

Early Biomarkers of Fabry Nephropathy: A Review of the Literature.

Riccio E, Sabbatini M, Capuano I, Pisani A.

Nephron. 2019 Oct 15:1-8. doi: 10.1159/000502907. [Epub ahead of print] Review.

3.

Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon.

Pratt-Riccio LR, Baptista BO, Torres VR, Bianco-Junior C, Perce-Da-Silva DS, Riccio EKP, Lima-Junior JDC, Totino PRR, Cassiano GC, Storti-Melo LM, Machado RLD, de Oliveira-Ferreira J, Banic DM, Carvalho LJM, Daniel-Ribeiro CT.

Mem Inst Oswaldo Cruz. 2019;114:e190054. doi: 10.1590/0074-02760190054. Epub 2019 Aug 12.

4.

Metabolic Disorders and Male Hypogonadotropic Hypogonadism.

Pivonello R, Menafra D, Riccio E, Garifalos F, Mazzella M, de Angelis C, Colao A.

Front Endocrinol (Lausanne). 2019 Jul 25;10:345. doi: 10.3389/fendo.2019.00345. eCollection 2019. Review.

5.

ADPKD and metformin: from bench to bedside.

Capuano I, Riccio E, Caccavallo S, De Simone I, Pisani A.

Clin Exp Nephrol. 2019 Nov;23(11):1341-1342. doi: 10.1007/s10157-019-01770-1. Epub 2019 Jul 26. No abstract available.

PMID:
31346894
6.

Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: A speckle tracking echocardiography analysis.

Esposito R, Santoro C, Sorrentino R, Riccio E, Citro R, Buonauro A, Di Risi T, Imbriaco M, Trimarco B, Pisani A, Galderisi M; Anderson-Fabry Federico II Naples, ITalY (AFFINIITY) Group.

Echocardiography. 2019 Jul;36(7):1273-1281. doi: 10.1111/echo.14399. Epub 2019 Jun 27.

PMID:
31246327
7.

Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease.

Spinelli L, Imbriaco M, Giugliano G, Nappi C, Gaudieri V, Riccio E, Pisani A, Trimarco B, Cuocolo A.

J Nucl Cardiol. 2019 May 13. doi: 10.1007/s12350-019-01734-8. [Epub ahead of print]

PMID:
31087266
8.

Plasmodium vivax ookinete surface protein (Pvs25) is highly conserved among field isolates from five different regions of the Brazilian Amazon.

Chaves LB, Perce-da-Silva DS, Totino PRR, Riccio EKP, Baptista BO, de Souza ABL, Rodrigues-da-Silva RN, Machado RLD, de Souza RM, Daniel-Ribeiro CT, Banic DM, Pratt-Riccio LR, Lima-Junior JDC.

Infect Genet Evol. 2019 Sep;73:287-294. doi: 10.1016/j.meegid.2019.05.003. Epub 2019 May 8.

PMID:
31077839
9.

Optical Coherence Tomography Angiography Findings in Fabry Disease.

Cennamo G, Di Maio LG, Montorio D, Tranfa F, Russo C, Pontillo G, Cocozza S, Esposito R, Di Risi T, Imbriaco M, Spinelli L, Riccio E, Pisani A.

J Clin Med. 2019 Apr 17;8(4). pii: E528. doi: 10.3390/jcm8040528.

10.

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.

Perico N, Ruggenenti P, Perna A, Caroli A, Trillini M, Sironi S, Pisani A, Riccio E, Imbriaco M, Dugo M, Morana G, Granata A, Figuera M, Gaspari F, Carrara F, Rubis N, Villa A, Gamba S, Prandini S, Cortinovis M, Remuzzi A, Remuzzi G; ALADIN 2 Study Group.

PLoS Med. 2019 Apr 5;16(4):e1002777. doi: 10.1371/journal.pmed.1002777. eCollection 2019 Apr.

11.

Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.

Imbriaco M, Nappi C, Ponsiglione A, Pisani A, Dell'Aversana S, Nicolai E, Spinelli L, Aiello M, Diomiaiuti CT, Riccio E, Esposito R, Galderisi M, Losi M, Greiser A, Chow K, Cuocolo A.

Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1004-1011. doi: 10.1093/ehjci/jez039.

PMID:
30879055
12.

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.

Ruggenenti P, Trillini M, P Barlovic D, Cortinovis M, Pisani A, Parvanova A, Iliev IP, Ruggiero B, Rota S, Aparicio MC, Perna A, Peraro F, Diadei O, Gaspari F, Carrara F, Stucchi N, Martinetti D, Janez A, Gregoric N, Riccio E, Bossi AC, Trevisan R, Manunta P, Battaglia G, David S, Aucella F, Belviso A, Satta A, Remuzzi G; VALID Study Organization.

Diabetes Obes Metab. 2019 May;21(5):1177-1190. doi: 10.1111/dom.13639. Epub 2019 Feb 22.

PMID:
30793466
13.

Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival.

Sabbatini M, Ferreri L, Pisani A, Capuano I, Morgillo M, Memoli A, Riccio E, Guida B.

Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):319-324. doi: 10.1016/j.numecd.2019.01.002. Epub 2019 Jan 12.

PMID:
30782507
14.

Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report.

Lupoli GA, Barba L, Liotti A, La Civita E, Lupoli R, Riccio E, Portella G, Formisano P, Beguinot F, Terracciano D.

Medicine (Baltimore). 2019 Feb;98(5):e14178. doi: 10.1097/MD.0000000000014178.

15.

Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients.

Spinelli L, Pisani A, Giugliano G, Trimarco B, Riccio E, Visciano B, Remuzzi G, Ruggenenti P.

Data Brief. 2018 Nov 14;21:2075-2081. doi: 10.1016/j.dib.2018.11.041. eCollection 2018 Dec.

16.

Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial.

Spinelli L, Pisani A, Giugliano G, Trimarco B, Riccio E, Visciano B, Remuzzi G, Ruggenenti P; ALADIN-Cardiovascular Study Group.

Int J Cardiol. 2019 Jan 15;275:145-151. doi: 10.1016/j.ijcard.2018.10.063. Epub 2018 Oct 22.

PMID:
30509370
17.

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

Duro G, Zizzo C, Cammarata G, Burlina A, Burlina A, Polo G, Scalia S, Oliveri R, Sciarrino S, Francofonte D, Alessandro R, Pisani A, Palladino G, Napoletano R, Tenuta M, Masarone D, Limongelli G, Riccio E, Frustaci A, Chimenti C, Ferri C, Pieruzzi F, Pieroni M, Spada M, Castana C, Caserta M, Monte I, Rodolico MS, Feriozzi S, Battaglia Y, Amico L, Losi MA, Autore C, Lombardi M, Zoccali C, Testa A, Postorino M, Mignani R, Zachara E, Giordano A, Colomba P.

Int J Mol Sci. 2018 Nov 23;19(12). pii: E3726. doi: 10.3390/ijms19123726.

18.

Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease.

Riccio E, Sabbatini M, Bruzzese D, Annicchiarico Petruzzelli L, Pellegrino A, Spinelli L, Esposito R, Imbriaco M, Feriozzi S, Pisani A; on behalf of AFFIINITY Group.

Nephron. 2019;141(1):10-17. doi: 10.1159/000493469. Epub 2018 Nov 22.

PMID:
30466100
19.

Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?

Pisani A, Riccio E, Bruzzese D, Sabbatini M.

BMC Nephrol. 2018 Oct 22;19(1):282. doi: 10.1186/s12882-018-1090-3.

20.

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis.

Ugga L, Cocozza S, Pontillo G, Russo C, Brescia Morra V, Lanzillo R, Riccio E, Pisani A, Brunetti A.

Brain Behav. 2018 Nov;8(11):e01121. doi: 10.1002/brb3.1121. Epub 2018 Oct 2.

21.

Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family.

Russo C, Riccio E, Pontillo G, Cocozza S, Tedeschi E, Centonze D, Pisani A.

Mult Scler Relat Disord. 2018 Nov;26:164-167. doi: 10.1016/j.msard.2018.09.019. Epub 2018 Sep 19.

PMID:
30268036
22.

Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?

Pontillo G, Cocozza S, Brunetti A, Brescia Morra V, Riccio E, Russo C, Saccà F, Tedeschi E, Pisani A, Quarantelli M.

Front Neurol. 2018 Aug 17;9:672. doi: 10.3389/fneur.2018.00672. eCollection 2018.

23.

Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients.

Esposito R, Galderisi M, Santoro C, Imbriaco M, Riccio E, Maria Pellegrino A, Sorrentino R, Lembo M, Citro R, Angela Losi M, Spinelli L, Trimarco B, Pisani A.

Eur Heart J Cardiovasc Imaging. 2019 Apr 1;20(4):438-445. doi: 10.1093/ehjci/jey108.

PMID:
30085001
24.

Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study.

Russo C, Pontillo G, Pisani A, Saccà F, Riccio E, Macera A, Rusconi G, Stanzione A, Borrelli P, Brescia Morra V, Tedeschi E, Brunetti A, Cocozza S, Palma G.

Parkinsonism Relat Disord. 2018 Dec;57:27-32. doi: 10.1016/j.parkreldis.2018.07.011. Epub 2018 Jul 21.

PMID:
30054181
25.

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.

Cammarata G, Scalia S, Colomba P, Zizzo C, Pisani A, Riccio E, Montalbano M, Alessandro R, Giordano A, Duro G.

Oncotarget. 2018 Jun 8;9(44):27333-27345. doi: 10.18632/oncotarget.25542. eCollection 2018 Jun 8.

26.

Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.

Spinelli L, Imbriaco M, Nappi C, Nicolai E, Giugliano G, Ponsiglione A, Diomiaiuti TC, Riccio E, Duro G, Pisani A, Trimarco B, Cuocolo A.

Circ Cardiovasc Imaging. 2018 Apr;11(4):e007019. doi: 10.1161/CIRCIMAGING.117.007019.

PMID:
29626078
27.

Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations.

Cocozza S, Pontillo G, Quarantelli M, Saccà F, Riccio E, Costabile T, Olivo G, Brescia Morra V, Pisani A, Brunetti A, Tedeschi E; AFFINITY study group.

Hum Brain Mapp. 2018 Apr;39(4):1755-1764. doi: 10.1002/hbm.23949. Epub 2018 Jan 9.

PMID:
29315984
28.

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy.

Scionti F, Di Martino MT, Sestito S, Nicoletti A, Falvo F, Roppa K, Arbitrio M, Guzzi PH, Agapito G, Pisani A, Riccio E, Concolino D, Pensabene L.

Oncotarget. 2017 Nov 18;8(64):107558-107564. doi: 10.18632/oncotarget.22505. eCollection 2017 Dec 8.

29.

Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.

Peluso G, Incollingo P, Calogero A, Tammaro V, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Dodaro CA, Carlomagno N.

Biomed Res Int. 2017;2017:2605628. doi: 10.1155/2017/2605628. Epub 2017 Oct 29. Review.

30.

Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.

Riccio E, Sabbatini M, Bruzzese D, Grumetto L, Marchetiello C, Amicone M, Andreucci M, Guida B, Passaretti D, Russo G, Pisani A.

Clin Exp Nephrol. 2018 Jun;22(3):529-538. doi: 10.1007/s10157-017-1504-8. Epub 2017 Nov 20.

PMID:
29159529
31.

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.

Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M.

Biomed Res Int. 2017;2017:7869802. doi: 10.1155/2017/7869802. Epub 2017 Sep 28. Review.

32.

Redefining the Pulvinar Sign in Fabry Disease.

Cocozza S, Russo C, Pisani A, Olivo G, Riccio E, Cervo A, Pontillo G, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Mignani R, Borrelli P, Imbriaco M, Brunetti A, Tedeschi E, Palma G.

AJNR Am J Neuroradiol. 2017 Dec;38(12):2264-2269. doi: 10.3174/ajnr.A5420. Epub 2017 Oct 19.

33.

Increased Plasmodium falciparum Parasitemia in Non-splenectomized Saimiri sciureus Monkeys Treated with Clodronate Liposomes.

Cunha JA, Carvalho LJM, Bianco-Junior C, Andrade MCR, Pratt-Riccio LR, Riccio EKP, Pelajo-Machado M, da Silva IJ, Druilhe P, Daniel-Ribeiro CT.

Front Cell Infect Microbiol. 2017 Sep 21;7:408. doi: 10.3389/fcimb.2017.00408. eCollection 2017.

34.

Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease.

Imbriaco M, Pellegrino T, Piscopo V, Petretta M, Ponsiglione A, Nappi C, Puglia M, Dell'Aversana S, Riccio E, Spinelli L, Pisani A, Cuocolo A.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2266-2273. doi: 10.1007/s00259-017-3778-1. Epub 2017 Jul 22.

PMID:
28733764
35.

Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

Manna R, Cauda R, Feriozzi S, Gambaro G, Gasbarrini A, Lacombe D, Livneh A, Martini A, Ozdogan H, Pisani A, Riccio E, Verrecchia E, Dagna L; International Panel for RAre recurrent FUO-IPRAFUO.

Intern Emerg Med. 2017 Oct;12(7):1059-1067. doi: 10.1007/s11739-017-1704-y. Epub 2017 Jul 19.

PMID:
28726033
36.

Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

Cocozza S, Pisani A, Olivo G, Saccà F, Ugga L, Riccio E, Migliaccio S, Brescia Morra V, Brunetti A, Quarantelli M, Tedeschi E.

Neurology. 2017 May 9;88(19):1822-1829. doi: 10.1212/WNL.0000000000003913. Epub 2017 Apr 12.

PMID:
28404798
37.

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Cocozza S, Olivo G, Riccio E, Russo C, Pontillo G, Ugga L, Migliaccio S, de Rosa D, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Tuttolomondo A, Caronia A, Russo CV, Lanzillo R, Brescia Morra V, Imbriaco M, Brunetti A, Tedeschi E, Pisani A.

Neuroradiology. 2017 Jun;59(6):563-570. doi: 10.1007/s00234-017-1829-8. Epub 2017 Apr 6.

PMID:
28386689
38.

Parapelvic cysts, a distinguishing feature of renal Fabry disease.

Pisani A, Petruzzelli Annicchiarico L, Pellegrino A, Bruzzese D, Feriozzi S, Imbriaco M, Tedeschi E, Cocozza S, De Rosa D, Mignani R, Veroux M, Battaglia Y, Concolino D, Sestito S, Pieruzzi F, Caroti L, Manna R, Zizzo C, Santangelo M, Sabbatini M, Riccio E.

Nephrol Dial Transplant. 2018 Feb 1;33(2):318-323. doi: 10.1093/ndt/gfx009.

PMID:
28371803
39.

Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Manguso F, Bennato R, Lombardi G, Riccio E, Costantino G, Fries W.

PLoS One. 2016 Nov 15;11(11):e0166455. doi: 10.1371/journal.pone.0166455. eCollection 2016. Review.

40.

Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review.

Santangelo ML, Grifasi C, Criscitiello C, Giuliano M, Calogero A, Dodaro C, Incollingo P, Rupealta N, Candida M, Chiacchio G, Riccio E, Pisani A, Tammaro V, Carlomagno N.

Aging Clin Exp Res. 2017 Feb;29(Suppl 1):73-78. doi: 10.1007/s40520-016-0656-9. Epub 2016 Nov 11. Review.

PMID:
27837464
41.

Genetic variants associated with gastrointestinal symptoms in Fabry disease.

Di Martino MT, Scionti F, Sestito S, Nicoletti A, Arbitrio M, Hiram Guzzi P, Talarico V, Altomare F, Sanseviero MT, Agapito G, Pisani A, Riccio E, Borrelli O, Concolino D, Pensabene L.

Oncotarget. 2016 Dec 27;7(52):85895-85904. doi: 10.18632/oncotarget.13135.

42.

The potential use of biomarkers in predicting contrast-induced acute kidney injury.

Andreucci M, Faga T, Riccio E, Sabbatini M, Pisani A, Michael A.

Int J Nephrol Renovasc Dis. 2016 Sep 9;9:205-21. doi: 10.2147/IJNRD.S105124. eCollection 2016. Review.

43.

Switch to agalsidase alfa after shortage of agalsidase beta in Fabry disease: a systematic review and meta-analysis of the literature.

Pisani A, Bruzzese D, Sabbatini M, Spinelli L, Imbriaco M, Riccio E.

Genet Med. 2017 Mar;19(3):275-282. doi: 10.1038/gim.2016.117. Epub 2016 Sep 8. Review.

PMID:
27608175
44.

La pietra della follia.

Del Riccio E.

Riv Psichiatr. 2016 Jan-Feb;51(1):43. doi: 10.1708/2168.23454. Italian. No abstract available.

PMID:
27030349
45.

Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease.

Pisani A, Sabbatini M, Imbriaco M, Riccio E, Rubis N, Prinster A, Perna A, Liuzzi R, Spinelli L, Santangelo M, Remuzzi G, Ruggenenti P; ALADIN Study Group.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):1022-1030.e4. doi: 10.1016/j.cgh.2015.12.049. Epub 2016 Feb 1.

PMID:
26844873
46.

Molecular and clinical studies in five index cases with novel mutations in the GLA gene.

Zizzo C, Monte I, Pisani A, Fatuzzo P, Riccio E, Rodolico MS, Colomba P, Uva M, Cammarata G, Alessandro R, Iemolo F, Duro G.

Gene. 2016 Mar 1;578(1):100-4. doi: 10.1016/j.gene.2015.12.024. Epub 2015 Dec 12.

PMID:
26691501
47.

Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.

Spinelli L, Pellegrino T, Pisani A, Giudice CA, Riccio E, Imbriaco M, Salvatore M, Trimarco B, Cuocolo A.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):729-39. doi: 10.1007/s00259-015-3273-5. Epub 2015 Dec 7.

PMID:
26639748
48.

Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease.

Pisani A, Daniele A, Di Domenico C, Nigro E, Salvatore F, Riccio E.

BMC Res Notes. 2015 Nov 24;8:711. doi: 10.1186/s13104-015-1696-5.

49.

[Me pinxit, me fecit].

Del Riccio E.

Riv Psichiatr. 2015 Sep-Oct;50(5):253. doi: 10.1708/2040.22170. Italian. No abstract available.

PMID:
26489075
50.

6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial.

Pisani A, Riccio E, Bellizzi V, Caputo DL, Mozzillo G, Amato M, Andreucci M, Cianciaruso B, Sabbatini M.

Clin Exp Nephrol. 2016 Jun;20(3):433-42. doi: 10.1007/s10157-015-1172-5. Epub 2015 Oct 9.

PMID:
26453483

Supplemental Content

Loading ...
Support Center